Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
121.50    0.50 (0.41%)
Bid:
121.50
Ask:
123.50
Spread: 2.00 (1.646%)
Market Cap: £281.29m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

Pre-stabilisation announcement replacement

9 Mar 2015 12:43

RNS Number : 9130G
UBS Limited
09 March 2015
Β 

ο»Ώ

The following amendment has been made to the 'Pre-stabilisation announcement' released on 06 March 2015 at 07:17 under RNS No. 7437G.

Β 

The offer price has been corrected to 255p.

Β 

All other details remain unchanged.

Β 

The full amended text is shown below.

Β 

Β 

Pre-stabilisation announcement

Β 

Β 

Not for distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any jurisdiction in which such distribution would be unlawful.

Β 

Β 

DFS Furniture plc

Stabilisation Notice

Β 

Β 

Β 

UBS Limited (contact: Gareth McCartney; telephone: 0044 20756 82227) hereby gives notice that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6) and MAR 2.3.5 (1) of the Financial Conduct Authority Code of Market Conduct

Β 

The Securities:

Issuer:

DFS Furniture plc

Offering securities:

Ordinary Shares of 150 pence each

ISIN: GB00BTC0LB89

Offering description:

Initial Public Offering of Ordinary Shares

Offering size:

Β 80,943,786 Ordinary Shares (excluding Over-allotment Option)

Offer price:

255 pence per Ordinary Share

Stabilisation:

Stabilisation Manager:

UBS Limited

Β 

Stabilisation period expected to start on:

Approximately 8.00 a.m. (London time) on 6 March 2015

Stabilisation period expected to end no later than:

Close of business on 5 April 2015

Maximum size of over-allotment facility:

12,142,744 Ordinary Shares

Conditions of use of over-allotment facility:

Β 

May be exercised in whole or in part by the Stabilisation Manager, to the extent permitted by applicable law, at any time during the period commencing with conditional dealings and ending 30 days thereafter

Over-allotment Option:

Terms:

Advent Diamond (Luxembourg) S.Γ  r.l. has granted UBS Limited, in its capacity as Stabilisation Manager and for the account of the underwriters, the option to acquire up to an additional 12,142,744 Ordinary Shares

Exercise period:

30 days from the start of conditional dealings (ending close of business 5 April 2015)

Β 

Β 

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager will take any Stabilisation action and any Stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

Β 

Β 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

Β 

Β 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

Β 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

Β 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STASSEFEUFISELD
Date   Source Headline
6th Apr 20227:00 amRNSTransaction in Own Shares
5th Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 20227:00 amRNSTransaction in Own Shares
1st Apr 20223:00 pmRNSTotal Voting Rights
1st Apr 20227:00 amRNSTransaction in Own Shares
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20221:07 pmRNSHolding(s) in Company
25th Mar 20227:00 amRNSTransaction in Own Shares
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSTransaction in Own Shares
18th Mar 20225:45 pmRNSHolding(s) in Company
18th Mar 20227:00 amRNSDirector/PDMR Shareholding
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:15 amRNSShare Buyback Programme
15th Mar 20227:00 amRNSHalf-year Report
4th Mar 202212:57 pmRNSTotal Voting Rights
21st Feb 20224:01 pmRNSHolding(s) in Company
4th Feb 202210:39 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTotal Voting Rights
14th Jan 20227:06 amRNSHolding(s) in Company
12th Jan 20227:00 amRNSInterim Trading Statement
31st Dec 202112:36 pmRNSPrice Monitoring Extension
21st Dec 20217:10 amRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSDirector/PDMR Shareholding
29th Nov 20219:17 amRNSDirector/PDMR Shareholding
24th Nov 202112:56 pmRNSPurchase of shares by Employee Benefit Trust
23rd Nov 20211:36 pmRNSPURCHASE OF SHARES BY EMPLOYEE BENEFIT TRUST
12th Nov 20214:23 pmRNSDirector/PDMR Shareholding
12th Nov 20213:51 pmRNSResults of Annual General Meeting
1st Nov 20219:31 amRNSTotal Voting Rights
21st Oct 202111:01 amRNSDirector/PDMR Shareholding
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
11th Oct 20217:00 amRNSAnnual Financial Report
4th Oct 202112:27 pmRNSINTENDED PURCHASE OF SHARES BY EBT
4th Oct 20218:24 amRNSDirector Declaration
23rd Sep 20217:00 amRNSPreliminary Results
28th Jun 20217:30 amRNSDirectorate Change
10th Jun 20217:00 amRNSPre-Close Trading Statement
8th Jun 20217:00 amRNSHolding(s) in Company
24th May 202111:16 amRNSHolding(s) in Company
30th Mar 202110:50 amRNSDirector/PDMR Shareholding
10th Mar 20213:42 pmRNSReplacement Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.